» Articles » PMID: 32514646

Epstein-Barr Virus-associated Gastric Cancer: Disease That Requires Special Approach

Overview
Journal Gastric Cancer
Date 2020 Jun 10
PMID 32514646
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Epstein-Barr virus-associated gastric cancer [EBV-associated GC, EBV( +) GC] is a distinct molecular subtype of gastrointestinal (GI) cancers. It accounts for up to 10% of all molecular subtypes of gastric cancer (GC). It has unique genetic and epigenetic features, which determine its definitive phenotype with male and younger age predominance, proximal stomach localization, and diffuse adenocarcinoma histology. EBV( +) GC also has a unique epigenetic profile and mutational status with frequent mutations of PIK3CA, ARID1A and BCOR, and PD-L1 and PD-L2 amplifications, as well. The aim of this review is to highlight clinical significance of EBV( +) GC and prognostic role of EBV infection, and to determine potentially appropriate drug therapy for this disease.

Citing Articles

Interplay of aurora kinase a functional residues and Epstein-barr Nuclear Antigen 1 in Epstein-barr virus associated Gastric cancer using AGS cells.

Varshney N, Singh S, Kandpal M, Saini V, Roberston E, Jha H BMC Cancer. 2025; 25(1):143.

PMID: 39856614 PMC: 11762537. DOI: 10.1186/s12885-024-13260-z.


Association of PD-L1 positivity with Epstein Barr virus infection and microsatellite instability in gastric carcinomas with lymphoid stroma.

Lee S, Oh H Sci Rep. 2024; 14(1):30932.

PMID: 39730741 PMC: 11680954. DOI: 10.1038/s41598-024-81764-6.


The landscape of 142 Epstein-Barr viral whole genomes in gastric cancer.

Kojima Y, Hamada M, Naruse A, Goto K, Khine H, Arai H J Gastroenterol. 2024; 60(1):55-65.

PMID: 39572460 DOI: 10.1007/s00535-024-02170-3.


Low EBI3 Expression Promotes the Malignant Degree of Gastric Cancer.

Gu Q, Wu H, Cheng Z, Zhi X, Song Q, Chen X Dis Markers. 2024; 2022:5588043.

PMID: 39291183 PMC: 11407894. DOI: 10.1155/2022/5588043.


The Epstein-Barr virus-miRNA-BART6-5p regulates TGF-β/SMAD4 pathway to induce glycolysis and enhance proliferation and metastasis of gastric cancer cells.

Zhao X, Huang X, Dang C, Wang X, Qi Y, Li H Oncol Res. 2024; 32(5):999-1009.

PMID: 38686046 PMC: 11055990. DOI: 10.32604/or.2024.046679.


References
1.
Akiba S, Koriyama C, Herrera-Goepfert R, Eizuru Y . Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci. 2008; 99(2):195-201. PMC: 11158035. DOI: 10.1111/j.1349-7006.2007.00674.x. View

2.
Liu Y, Sethi N, Hinoue T, Schneider B, Cherniack A, Sanchez-Vega F . Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell. 2018; 33(4):721-735.e8. PMC: 5966039. DOI: 10.1016/j.ccell.2018.03.010. View

3.
Fukayama M . Epstein-Barr virus and gastric carcinoma. Pathol Int. 2010; 60(5):337-50. DOI: 10.1111/j.1440-1827.2010.02533.x. View

4.
Yanai H, Nishikawa J, Mizugaki Y, Shimizu N, Takada K, Matsusaki K . Endoscopic and pathologic features of Epstein-Barr virus-associated gastric carcinoma. Gastrointest Endosc. 1997; 45(3):236-42. DOI: 10.1016/s0016-5107(97)70265-7. View

5.
Nishikawa J, Yanai H, Mizugaki Y, Takada K, Tada M, Okita K . Case report: hypoechoic submucosal nodules: a sign of Epstein-Barr virus-associated early gastric cancer. J Gastroenterol Hepatol. 1998; 13(6):585-90. DOI: 10.1111/j.1440-1746.1998.tb00694.x. View